EA201400193A1 - Наночастицы оксидных ферримагнетиков со структурой шпинели и наночастицы оксидов железа, биосовместимые водные коллоидные системы, включающие в себя наночастицы, феррилипосомы, и их использование - Google Patents
Наночастицы оксидных ферримагнетиков со структурой шпинели и наночастицы оксидов железа, биосовместимые водные коллоидные системы, включающие в себя наночастицы, феррилипосомы, и их использованиеInfo
- Publication number
- EA201400193A1 EA201400193A1 EA201400193A EA201400193A EA201400193A1 EA 201400193 A1 EA201400193 A1 EA 201400193A1 EA 201400193 A EA201400193 A EA 201400193A EA 201400193 A EA201400193 A EA 201400193A EA 201400193 A1 EA201400193 A1 EA 201400193A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- nanoparticles
- oxide
- ferrimagnets
- spinel structure
- ferriliposomy
- Prior art date
Links
- 239000002105 nanoparticle Substances 0.000 title abstract 8
- 239000011029 spinel Substances 0.000 title abstract 5
- 229910052596 spinel Inorganic materials 0.000 title abstract 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 title abstract 4
- 239000000084 colloidal system Substances 0.000 title abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 235000013980 iron oxide Nutrition 0.000 abstract 2
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 abstract 2
- 229940031182 nanoparticles iron oxide Drugs 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G49/00—Compounds of iron
- C01G49/02—Oxides; Hydroxides
- C01G49/08—Ferroso-ferric oxide [Fe3O4]
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G51/00—Compounds of cobalt
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/0036—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
- H01F1/0045—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
- H01F1/0054—Coated nanoparticles, e.g. nanoparticles coated with organic surfactant
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/30—Three-dimensional structures
- C01P2002/32—Three-dimensional structures spinel-type (AB2O4)
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/50—Solid solutions
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/03—Particle morphology depicted by an image obtained by SEM
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/51—Particles with a specific particle size distribution
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/51—Particles with a specific particle size distribution
- C01P2004/52—Particles with a specific particle size distribution highly monodisperse size distribution
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/64—Nanometer sized, i.e. from 1-100 nanometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/12—Surface area
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
- H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
- H01F1/01—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials
- H01F1/03—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity
- H01F1/12—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials
- H01F1/34—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties of inorganic materials characterised by their coercivity of soft-magnetic materials non-metallic substances, e.g. ferrites
- H01F1/342—Oxides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Power Engineering (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Compounds Of Iron (AREA)
- Medicinal Preparation (AREA)
Abstract
Предметом настоящего изобретения являются способы получения наночастиц оксидных ферримагнетиков со структурой шпинели и наночастиц оксидов железа на основе механохимического синтеза, наночастицы оксидных ферримагнетиков со структурой шпинели и наночастицы оксидов железа сверхмалого размера с большой удельной поверхностью, получаемые данными способами, биосовместимые водные коллоидные системы, включающие в себя наночастицы оксидных ферримагнетиков со структурой шпинели и наночастицы оксидов железа, феррилипосомы, содержащие наночастицы оксидных ферримагнетиков со структурой шпинели и наночастицы оксидов железа, и способы их применения в медицине.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RU2011/000574 WO2013019137A1 (en) | 2011-08-04 | 2011-08-04 | Oxide ferrimagnetics with spinel structure nanoparticles and iron oxide nanoparticles, biocompatible aqueous colloidal systems comprising nanoparticles, ferriliposomes, and uses thereof |
RU2011132913/15A RU2471502C1 (ru) | 2011-08-04 | 2011-08-04 | Контрастное средство для t1 и/или t2 магнитно-резонансного сканирования и способ его получения |
PCT/RU2012/000632 WO2013019151A2 (en) | 2011-08-04 | 2012-08-03 | Oxide ferrimagnetics with spinel structure nanoparticles and iron oxide nanoparticles, biocompatible aqueous colloidal systems comprising nanoparticles, ferriliposomes, and uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201400193A1 true EA201400193A1 (ru) | 2014-11-28 |
EA029170B1 EA029170B1 (ru) | 2018-02-28 |
Family
ID=47629828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201400193A EA029170B1 (ru) | 2011-08-04 | 2012-08-03 | Наночастицы оксидных ферримагнетиков со структурой шпинели и наночастицы оксидов железа, биосовместимые водные коллоидные системы, включающие в себя наночастицы, феррилипосомы, и их использование |
Country Status (5)
Country | Link |
---|---|
US (1) | US20140186268A1 (ru) |
EP (1) | EP2739291A4 (ru) |
BR (1) | BR112014002755A2 (ru) |
EA (1) | EA029170B1 (ru) |
WO (1) | WO2013019151A2 (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8954131B2 (en) * | 2007-06-19 | 2015-02-10 | The Trustees Of Dartmouth College | Magnetic particle imaging (MPI) system and method for use of iron-based nanoparticles in imaging and diagnosis |
CN104538145B (zh) * | 2014-12-08 | 2017-02-22 | 浙江师范大学 | 一种多尺度、均一、单分散磁性微球及其制备方法 |
CN105931786A (zh) * | 2016-07-14 | 2016-09-07 | 安徽万磁电子有限公司 | 一种镝钇离子注入的镀镍钕铁硼磁体及其制备方法 |
US11348702B2 (en) * | 2016-08-11 | 2022-05-31 | Battelle Memorial Institute | System, emanation generator, and process for production of high-purity therapeutic radioisotopes |
CN106421813B (zh) * | 2016-10-21 | 2019-07-26 | 新乡医学院 | 具有双重靶向功能的载药纳米粒子及其制备方法和应用 |
CN109626439B (zh) * | 2018-12-11 | 2024-05-07 | 中国科学院宁波材料技术与工程研究所 | 一种金属掺杂铁氧体纳米材料、包含其的磁性纳米粒子的制备方法及其应用 |
US11207348B2 (en) | 2019-04-25 | 2021-12-28 | Imam Abdulrahman Bin Faisal University | Spinel ferrite impregnated mesoporous silica containing a platinum complex |
CN110124036B (zh) * | 2019-06-10 | 2020-11-20 | 西安电子科技大学 | 多功能磁性纳米探针及其制备方法 |
CN112274657B (zh) * | 2020-09-17 | 2022-04-01 | 浙江大学 | 一种t1-t2双模态超高场磁共振造影剂及其制备方法和应用 |
CN113398285B (zh) * | 2021-06-09 | 2022-09-02 | 哈尔滨工程大学 | 一种具有抗肿瘤效应的双金属纳米酶复合材料的制备方法 |
CN113484469B (zh) * | 2021-06-30 | 2022-11-18 | 中国科学院青海盐湖研究所 | 水合盐体系相变储能材料纳米尺度相分离的原位表征方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5411730A (en) * | 1993-07-20 | 1995-05-02 | Research Corporation Technologies, Inc. | Magnetic microparticles |
US20020012698A1 (en) * | 1999-09-01 | 2002-01-31 | Edmund Bauerlein | Magnetosomes, method for making and using |
ITFI20030038A1 (it) * | 2003-02-13 | 2004-08-14 | Colorobbia Italiana Spa | Composizioni comprendenti liposomi contenenti nanoparticelle |
WO2006051732A1 (ja) * | 2004-11-10 | 2006-05-18 | Konica Minolta Medical & Graphic, Inc. | 被覆磁性粒子含有製剤およびその製造方法、並びに診断治療システム |
-
2012
- 2012-08-03 BR BR112014002755A patent/BR112014002755A2/pt not_active IP Right Cessation
- 2012-08-03 WO PCT/RU2012/000632 patent/WO2013019151A2/en active Application Filing
- 2012-08-03 EA EA201400193A patent/EA029170B1/ru not_active IP Right Cessation
- 2012-08-03 EP EP12820347.8A patent/EP2739291A4/en not_active Withdrawn
-
2014
- 2014-02-04 US US14/172,401 patent/US20140186268A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EA029170B1 (ru) | 2018-02-28 |
EP2739291A4 (en) | 2015-03-11 |
US20140186268A1 (en) | 2014-07-03 |
WO2013019151A2 (en) | 2013-02-07 |
BR112014002755A2 (pt) | 2017-02-21 |
EP2739291A2 (en) | 2014-06-11 |
WO2013019151A3 (en) | 2013-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201400193A1 (ru) | Наночастицы оксидных ферримагнетиков со структурой шпинели и наночастицы оксидов железа, биосовместимые водные коллоидные системы, включающие в себя наночастицы, феррилипосомы, и их использование | |
PH12016501033B1 (en) | Oral care composition | |
IL235966B (en) | Aqueous compositions with a ph level of 6 containing anti-Baffr antibody without fucosylation for use in the treatment of autoimmune diseases | |
MX2020007227A (es) | Nanoparticulas farmaceuticas que muestran la mejora del transporte de la mucosa. | |
MX2014004116A (es) | Particulas precipitadas de carbonato de calcio y uso de las mismas. | |
MX2017002085A (es) | Tratamientos con nanopartículas núcleo-corteza de proteína/oligonucleótido. | |
MX2015007872A (es) | Complejo de zinc-lisina. | |
UY34192A (es) | ?proceso para reducir pez en medio acuoso; carbonato de calcio molido y/o precipitado hidrofobizado; y uso y compuesto del mismo?. | |
HUE037271T2 (hu) | Közel monodiszperz részecskék elõállítása alkalmazva méretcsökkentést vagy méretnövelést és membrános elkülönítést | |
MX2016003660A (es) | Conjugados de partícula similar a virus para el diagnóstico y tratamiento de tumores. | |
AU336201S (en) | Flask | |
EP2968148A4 (en) | METHOD FOR IMPROVING BIODISTRIBUTING AND TISSUE ARGETING PROPERTIES OF THERAPEUTIC CEO2 PARTICULARS THROUGH NANO ENCAPSULATION AND COATING | |
IN2014DN04773A (ru) | ||
MX357227B (es) | Nanoparticulas basadas en lipidos. | |
WO2013112643A8 (en) | Low density, highly porous nano structure | |
MX2016003238A (es) | Composiciones antisepticas cationicas. | |
EA201600412A1 (ru) | Способ производства неорганического материала в виде частиц | |
TWD173919S (zh) | 用於製成廢水廠中用來攪動廢水的攪動物體的元件 | |
WO2013109190A3 (en) | Cho-gmt recombinant protein expression | |
WO2016032148A3 (ko) | 서방출 및 생체 적합성이 개선된 카토제닌-키토산 복합체 입자 및 이의 이용 | |
WO2012084993A3 (en) | Biologically active oligonucleotides capable of modulating the immune system i | |
RU2012124113A (ru) | Наноструктурная водно-фосфоритная суспензия в качестве фосфорного удобрения под кукурузу | |
AU338124S (en) | Remote control | |
PL395684A1 (pl) | Nawóz cynkowy w formie zawiesiny zawierajacej tlenek cynku, sposób wytwarzania nawozu cynkowego w formie zawiesiny zawierajacej tlenek cynku oraz zastosowanie nawozu cynkowego w formie zawiesiny zawierajacej tlenek cynku | |
RU2012124112A (ru) | Наноструктурная водно-фосфоритная суспензия в качестве средства для предпосевной обработки семян огурца |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |